TrialPharmacology research & perspectives2020

Pan-cancer population pharmacokinetics and exposure-safety and -efficacy analyses of atezolizumab in patients with high tumor mutational burden.

Colby S Shemesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.